Eikon Therapeutics, Inc.
corporate_fare Company Profile
Eikon Therapeutics, Inc. (NASDAQ:EIKN) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 21 items for EIKN at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Eikon Therapeutics Completes Initial Public Offering, Raising $349 Million Net to Fund Clinical Pipeline
show_chartPrice Chart
Loading chart...
feed EIKN - Filings & News (Page 2)
EIKN
Feb 05, 2026, 4:05 PM EST
Price at Filing:
$14.70
Real-time Price:
$4.74
Change:
-$9.96 (-68%)
Market Cap:
$256.842M